FB2024_04 , released June 25, 2024
Human Disease Model Report: focal segmental glomerulosclerosis 3
Open Close
General Information
Name
focal segmental glomerulosclerosis 3
FlyBase ID
FBhh0000618
Overview

This report describes focal segmental glomerulosclerosis 3 (FSGS3), which is a subtype of focal segmental glomerulosclerosis; this disease is also described as a form of nephrotic syndrome (FBhh0000317). The gene implicated in FSGS3 is CD2AP (CD2 associated protein), which encodes an adapter protein between membrane proteins and the actin cytoskeleton. Haploinsufficiency of the CD2AP locus results in dominant inheritance of FSGS3, but at least one disease-associated variant exhibits autosomal recessive inheritance. There is a single orthologous gene in Drosophila, cindr, for which RNAi-targeting constructs and alleles caused by insertional mutagenesis have been generated. Dmel\cindr is orthologous to two additional human genes, SH3KBP1 and SH3D21. CD2AP has also been implicated in susceptibility to Alzheimer disease(FBhh0000260).

Multiple UAS constructs of the human Hsap\CD2AP gene have been introduced into flies, including wild-type and a variant tentatively associated with development of nephrotic syndrome. Variant(s) implicated in human disease tested (as transgenic human gene, CD2AP): the Y10F and K301M variant forms of the human gene have been introduced into flies. Partial heterologous rescue (functional complementation) has been demonstrated using the wild-type human transgene, assaying nephrocyte phenotypes, eye patterning phenotypes, and adult lifespan; rescue is not observed using the Y10F or K301M variant forms.

In the fly, nephrocytes act in a manner analogous to human podocytes: the fly nephrocyte diaphragm functions like the mammalian slit diaphragm to regulate filtration; the nephrocytes may also function in protein reabsorption [reviewed in FBrf0220711 and FBrf0235870; see also the human disease model report 'kidney disease (fly models overview)' FBhh0000738].

RNAi-effected reduction of cindr function in nephrocytes results in nephrocyte functional impairment and structural abnormalities; the animals also exhibit shortened adult life span. Extensive physical and genetic interactions of Dmel\cindr have been reported; see below and in the gene report for cindr.

[updated January 2020 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: focal segmental glomerulosclerosis
Symptoms and phenotype

Focal segmental glomerulosclerosis is one of many diseases and conditions can affect kidney function by attacking and damaging the glomeruli. "Glomerulosclerosis" refers to a hardening and scarring of the glomeruli. The scarring of FSGS takes place in small sections of each glomerulus, and only a limited number of glomeruli are damaged initially (https://www.kidney.org/atoz/content/focal).

A definitive diagnosis of FSGS is established only by histopathology findings (http://emedicine.medscape.com/article/245915-overview).

Focal segmental glomerulosclerosis (FSGS) is a pathologic finding in several renal disorders that manifest clinically as proteinuria and progressive decline in renal function. Some patients with FSGS develop nephrotic syndrome, which includes massive proteinuria, hypoalbuminemia, hyperlipidemia, and edema. However, patients with FSGS may have proteinuria in the nephrotic range without other features of the nephrotic syndrome (summary by D'Agati et al., 2004, pubmed:14750104; Mathis et al., 1998, pubmed:9461087). [from MIM:603278; 2017.09.14]

Focal segmental glomerulosclerosis is a common cause of end-stage renal disease (Meyrier, 2005; pubmed:16932363). [from MIM:607832; 2017.09.14]

In the literature, the clinical term 'nephrotic syndrome' (NPHS) and the pathologic term 'focal segmental glomerulosclerosis' (FSGS) have often been used to refer to the same disease entity. In OMIM, these disorders are classified as NPHS or FSGS according to how they were first designated in the literature. [from MIM:607832; 2017.09.14]

Specific Disease Summary: focal segmental glomerulosclerosis 3
OMIM report

[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3](https://omim.org/entry/607832)

Human gene(s) implicated

[CD2-ASSOCIATED PROTEIN; CD2AP](https://omim.org/entry/604241)

Symptoms and phenotype

See general description of focal segmental glomerulosclerosis.

Genetics

Susceptibility to focal segmental glomerulosclerosis-3 (FSGS3), is conferred by haploinsufficiency for CD2-associated protein (CD2AP). [from MIM:607832; 2017.09.14]

At least one mutation of CD2AP implicated in FSGS3 (R612X, truncation of last 27aa) exhibits autosomal recessive inheritance. [from MIM:604241; 2017.09.14]

Cellular phenotype and pathology

CD2AP is known to be a crucial protein for the slit-diaphragm assembly and function (Gigante et al., 2009; pubmed:19131354).

Molecular information

CD2AP encodes an adapter protein between membrane proteins and the actin cytoskeleton that directly interacts with filamentous actin and a variety of cell membrane proteins. One of its many functions appears to be anchoring the podocyte slit diaphragm to the actin cytoskeleton in renal glomeruli. [from Gene Cards, CD2AP; 2017.09.14]

External links
Disease synonyms
CD2AP-associated nephrotic syndrome
focal segmental glomerulosclerosis 3, susceptibility to
FSGS3
glomerulosclerosis, focal segmental 3
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 3 human to 1 Drosophila; the additional human genes are SH3KBP1 and SH3D21.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    CIN85 and CD2AP related (cindr) encodes an adaptor protein that links cell surface junctions and adhesion proteins with multiple components of the actin cytoskeleton. It regulates cytoskeletal dynamics, eye patterning and endocytosis. It also cooperates with the product of scra to promote intercellular bridge stability during cytokinesis. [Date last reviewed: 2019-03-07]
    Gene Groups / Pathways
      Comments on ortholog(s)

      Moderate-scoring ortholog of human CD2AP and SH3KBP1; low-scoring ortholog of SH3D21 (1 Drosophila to 3 human). Dmel\cindr shares 22-26% identity and 32-36% similarity with the human genes.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (36 groups)
        protein-protein
        Interacting group
        Assay
        References
        anti tag coimmunoprecipitation, western blot, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry, western blot
        pull down, anti tag western blot
        pull down, anti tag western blot
        anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti bait coimmunoprecipitation, peptide massfingerprinting
        anti bait coimmunoprecipitation, western blot, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting, experimental knowledge based
        anti tag coimmunoprecipitation, anti tag western blot
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, peptide massfingerprinting, experimental knowledge based
        anti bait coimmunoprecipitation, anti tag western blot, pull down, western blot
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        pull down, peptide massfingerprinting
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry, western blot
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, western blot, Identification by mass spectrometry
        anti bait coimmunoprecipitation, anti tag western blot, pull down, western blot
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        pull down, anti tag western blot
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, western blot, Identification by mass spectrometry
        anti tag coimmunoprecipitation, western blot, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, peptide massfingerprinting, experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (8 alleles)
        Models Based on Experimental Evidence ( 5 )
        Modifiers Based on Experimental Evidence ( 3 )
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        amorphic allele - molecular evidence
        FLPase
        References (7)